Active Ingredient: SUMATRIPTAN SUCCINATE
Proprietary Name: ONZETRA XSAIL
Dosage Form; Route of Administration: POWDER; NASAL
Strength: EQ 11MG BASE
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code:
Application Number: N206099
Product Number: 001
Approval Date: Jan 27, 2016
Applicant Holder Full Name: CURRAX PHARMACEUTICALS LLC
Marketing Status:
Prescription
Patent and Exclusivity Information
